Should we stop using intravenous gentamicin in patients with cystic fibrosis?
Christopher H
CH
Goss
D058186:Acute Kidney Injury / Q000139:chemically induced*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D016022:Case-Control Studies; D003550:Cystic Fibrosis / Q000188:drug therapy*; D005839:Gentamicins / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007262:Infusions, Intravenous
D000900:Anti-Bacterial Agents; D005839:Gentamicins